ReviewJournal of gastrointestinal cancer2026
Later-line Treatment Selection in Metastatic Colorectal Cancer: Trifluridine/Tipiracil Plus Bevacizumab, Regorafenib, and Fruquintinib.
Tamotsu Sagawa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.